| 國立成功大學 |
2023 |
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
|
Cheng, S.-H.;Lien, C.E.;Hsieh, S.-M.;Cheng, Cheng C.-Y.;Liu, W.-D.;Lo, C.-L.;Ko, W.-C.;Chen, Y.-H.;Huang, C.-T.;Chang, H.-T.;Hwang, S.-J.;Wang, N.-C.;Liu, M.-C.;Lee, Y.-L.;Tai, I.-C.;Estrada, J.A.G.;Lin, T.-Y.;Lee, W.-S. |
| 國立成功大學 |
2023 |
Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study
|
Tsai, C.-Y.;Chen, G.-J.;Tsai, C.-S.;Liou, B.-H.;Yang, C.-J.;Tsai, H.-C.;Lin, C.-Y.;Huang, S.-H.;Lin, K.-Y.;Wang, N.-C.;Chen, T.-C.;Lee, C.-H.;Hung, C.-C. |
| 國立成功大學 |
2023 |
An Efficient Lane Following Navigation Strategy With Fusion Attention for Autonomous Drones in Urban Areas
|
Lee, C.-Y.;Khanum, A.;Wang, N.-C.;Karuparthi, B.S.K.;Yang, C.-S. |
| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-05-13T08:05:20Z |
Antibiotic usage in community-acquired infections in hospitals in Taiwan
|
Ho M.; Chang F.-Y.; Yin H.-C.; Ben R.-J.; Chang L.-Y.; Chen P.-Y.; Cheng S.-H.; Chen S.-T.; Huang F.-L.; Lin H.-C.; Lu D.C.T.; Wang N.-C.; JANN-TAY WANG |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 國立成功大學 |
2022 |
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
|
Lin, K.-Y.;Yang, C.-J.;Sun, H.-Y.;Lee, Y.-T.;Liou, B.-H.;Hii, I.-M.;Chen, T.-C.;Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Lin, C.-Y.;Liu, C.-E.;Chang, H.-Y.;Cheng, Cheng C.-Y.;Lu, P.-L.;Hung, C.-C.;Huang, Y.-S.;Liu, W.-D.;Chen, G.-J.;Liu, W.-C.;Su, Y.-C.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Tsai, M.-S.;Lin, C.-C.;Lee, Y.-L.;Chen, Y.-H.;Huang, Y.-C.;Ko, W.-C.;Cheng, S.-H.;Chang, S.-Y.;Wang, N.-C.;Lin, T.-Y.;Lee, Y.-C.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Hung, T.-C.;Tsai, H.-C.;Lin, H.-H.;Lee, C.-H.;Group, Taiwan HIV Study |
| 臺大學術典藏 |
2021-12-01T02:30:34Z |
Correlates of antibiotic use in Taiwan hospitals
|
McDonald L.C.; Yu H.T.; Yin H.C.; Hsiung C.A.; CHIEN-CHING HUNG; Ho M.; Gung C.; Gung S.-T.; Hsu M.-C.; Ben R.-J.; Lu D.C.T.; Lin H.-C.; Cheng S.-H.; Chen Y.-H.; Chen P.-Y.; Huang F.-L.; Chang F.-Y.; Wang N.-C.; Antibiotic Use Working Group |
| 臺大學術典藏 |
2021-12-01T02:29:13Z |
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
|
Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; S?nchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Te?filo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serr?o R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Casta?o Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; Gonz?lez Cord?n A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Lia?o J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team |
| 臺大學術典藏 |
2021-12-01T02:29:10Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; Lin K.-Y.; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-12-01T02:29:09Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; Lin K.-Y.; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:08Z |
Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors
|
Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; Hung C.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; Hung C.-C. |
